Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
Cluster_Neurowissenschaften_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
  • Research
  • Education
  • Press Review
 
Neuroscience /
 
Subnavigation
    News
     

    Gabriele Fischer nominated again for Scientific Advisory Board of the EU Drugs Monitoring Centre

    The internationally renowned addiction expert Gabriele Fischer from the University Department of..

     

    Lukas Haider awarded with the Karl-Vass-Multiple-Sclerosis research prize - Radiologist of MedUni Wien was honoured for research in the field of multiple sclerosis

    The Karl Vass Multiple Sclerosis Research Award was presented to Lukas Haider from the Department..

     

    Tweets regarding suicide prevention might prevent suicide

    A scientific team led by Thomas Niederkrotenthaler and Hannah Metzler from MedUni Vienna and..

     

    Light therapy relieves fatigue syndrome in Multiple Sclerosis

    Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is..

     

    Potential new lead compounds for the treatment of depression and anxiety disorders

    Currently, various classes of drugs are available for the treatment of mental illnesses - such as..

     

    Neuronal mechanism involved in the learning of maternal behaviour discovered

    Various conditions such as postpartum depression or postpartum psychosis can lead to an alteration..

     

    Depression manifests differently in men than in women

    Fewer men than women are diagnosed as having depression. One possible reason for this is that there..

     
    Treffer 1 bis 7 von 169
    << Erste < Vorherige Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Nächste > Letzte >>
     
Inhaltsbereich

Brain cells identified for regulation of sleep-wake rhythm

A research team of the Center for Brain Research at the Medical University of Vienna has identified a specific cell group in the brain responsible for shifts in the sleep-wake rhythm caused by psychostimulants. A molecularly-defined cell population of the hypothalamus constitutes a point of control in the regulation of the circadian rhythm in the brain and gates the effect of psychostimulants through its activity. Through this neural mechanism, psychostimulants can cause an increase in alertness and activity, even during circadian periods of rest and sleep.

 

The circadian rhythm is the ability of animals to synchronize their physiological processes over a period of about 24 hours. This includes the sleep-wake rhythm as a central regulatory element. The center for controlling this brain function is located in the hypothalamus. People with irregular sleep-wake cycles, whether due to nocturnal activity or jet lag, often use psychostimulants to compensate the circadian shifts and correct their sleep rhythms.

The research team led by Tibor Harkany and Roman Romanov of the Department of Molecular Neuroscience at the Center for Brain Research of the Medical University of Vienna has now been able to identify a molecularly defined cell group (Th+/Dat1+) in the hypothalamus that is responsible for the circadian changes in activity patterns triggered by psychostimulants. Some people with chronic disturbances of their daily rhythms, such as pilots, are known to use the psychostimulant amphetamine in order to be able to stay awake and be active even during their biologically predetermined rest periods. The new study by the team of Tibor Harkany and Roman Romanov now tested and characterised this effect in a mouse model.

To this end, chemogenetic, optogenetic and behavioral methods were used to identify the group of cells in the hypothalamus that respond directly to the stimulants. The research team further revealed the functional circuitry in which these cells are embedded. They were able to identify the lateral septum, an area of the brain that regulates autonomic processes and is involved in the control of locomotion, as another important brain area involved in the regulatory processes induced by amphetamines.

"We could define a new region of the brain that is the lateral septum, which is involved in circadian rhythms via activity of dopamine receptors, where psychostimulants can exert their stimulatory effects. If the receptors there are inhibited or stimulated, it directly influences the activity of the organism," Roman Romanov explains
"Our new findings on the modulatory modes of the circadian rhythm offer starting points for new research on the functional effects of psychostimulants," adds Tibor Harkany, "With the identifcation of the receptors in the lateral septum, we open up a novel possibility for the development of new therapeutic approaches for the treatment of diseases associated with hyperactivity or shifts in circadian activity patterns

Publication: Nature Communications
A hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice
Solomiia Korchynska, Patrick Rebernik, Marko Pende, Laura Boi, Alán Alpár, Ramon Tasan, Klaus Becker, Kira Balueva, Saiedeh Saghafi, Peer Wulff, Tamas L. Horvath, Gilberto Fisone, Hans-Ulrich Dodt, Tomas Hökfelt, Tibor Harkany, and Roman A. Romanov

DOI: doi.org/10.1038/s41467-022-33584-3

zurück zu: Neuroscience
 
 
Print
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact